| 000 | 01538 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250514015206.0 | ||
| 264 | 0 | _c20020131 | |
| 008 | 200201s 0 0 eng d | ||
| 022 | _a0269-9370 | ||
| 024 | 7 |
_a10.1097/00002030-200111230-00006 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSterling, T R | |
| 245 | 0 | 0 |
_aHIV-1 RNA, CD4 T-lymphocytes, and clinical response to highly active antiretroviral therapy. _h[electronic resource] |
| 260 |
_bAIDS (London, England) _cNov 2001 |
||
| 300 |
_a2251-7 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aAntiretroviral Therapy, Highly Active _xstandards |
| 650 | 0 | 4 | _aCD4 Lymphocyte Count |
| 650 | 0 | 4 |
_aCD4-Positive T-Lymphocytes _xcytology |
| 650 | 0 | 4 | _aCohort Studies |
| 650 | 0 | 4 | _aDisease Progression |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHIV Infections _xdrug therapy |
| 650 | 0 | 4 |
_aHIV-1 _xgenetics |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aMultivariate Analysis |
| 650 | 0 | 4 |
_aRNA, Viral _xblood |
| 650 | 0 | 4 | _aSex Factors |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 | _aViral Load |
| 700 | 1 | _aChaisson, R E | |
| 700 | 1 | _aMoore, R D | |
| 773 | 0 |
_tAIDS (London, England) _gvol. 15 _gno. 17 _gp. 2251-7 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1097/00002030-200111230-00006 _zAvailable from publisher's website |
| 999 |
_c11614130 _d11614130 |
||